Evidence map›Paper›PMID 34518698›Full record

ArticleNature structural & molecular biology2021

De novo design of tyrosine and serine kinase-driven protein switches.

Nicholas B Woodall, Zara Weinberg, Jesslyn Park, Florian Busch, Richard S Johnson, Mikayla J Feldbauer, Michael Murphy, Maggie Ahlrichs, Issa Yousif, Michael J MacCoss and 3 more

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. bioRxiv : the preprint server for biology · 2025
    Article
  6. A Designed ZnJournal of the American Chemical Society · 2025
    Article
  7. Article
  8. Perspectives on Synthetic Protein Circuits in Mammalian Cells.Current opinion in biomedical engineering · 2024
    Article
  9. Engineering signalling pathways in mammalian cells.Nature biomedical engineering · 2024
    Review
  10. Article
  11. Article
  12. Expanding Native Mass Spectrometry to the Masses.Journal of the American Society for Mass Spectrometry · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Engineering synthetic phosphorylation signaling networks in human cells.bioRxiv : the preprint server for biology · 2023
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Nicholas B WoodallDepartment of Biochemistry, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-2423-6590
Zara WeinbergDepartment of Biochemistry & Biophysics, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-7176-038X
Jesslyn ParkDepartment of Biochemistry & Biophysics, University of California San Francisco, San Francisco, CA, USA.
Florian BuschDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-4324-6065
Richard S JohnsonDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-8150-1338
Mikayla J FeldbauerInstitute for Protein Design, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-4936-8979
Michael MurphyInstitute for Protein Design, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-8438-2653
Maggie AhlrichsInstitute for Protein Design, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-4793-3890
Issa YousifDepartment of Biochemistry, University of Washington, Seattle, WA, USA.
Michael J MacCossDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0003-1853-0256
Vicki H WysockiDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, USA.ORCID http://orcid.org/0000-0003-0495-2538
Hana El-SamadDepartment of Biochemistry & Biophysics, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-6239-9916
David BakerDepartment of Biochemistry, University of Washington, Seattle, WA, USA. dabaker@uw.edu.ORCID http://orcid.org/0000-0001-7896-6217
University of Washington · USUniversity of California, San Francisco · USHoward Hughes Medical Institute · USThe Ohio State University · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Jennifer A. Woyach · 1985 to 2026
$132.3M
User Training and OutreachP30GM124169 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI PAUL David ADAMS, Gregory L Hura · 2017 to 2026
$28.6M
TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI YATES III, JOHN R · 2012 to 2021
$20.7M
UCSF IRACDA Scholars ProgramK12GM081266 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Raymond M. Esquerra, HOLLY A. INGRAHAM · 2007 to 2026
$19.4M
Project 4: Novel reagent development to enable molecular characterizationU19AG065156 · NIA · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2020 to 2024
$15.9M
GENETICS OF EUCARYOTIC AND PROCARYOTIC ORGANISMST32GM007810 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ASHRAFI, KAVEH, NARLIKAR, GEETA J · 1985 to 2020
$15.1M
Waters Select Series Cyclic IMS for P41 Native MS Resource Application to Alzheimer's DiseaseP41GM128577 · NIGMS · OHIO STATE UNIVERSITY · PI WYSOCKI, VICKI H. · 2018 to 2022
$7.6M
MINOS (Macromolecular Insights on Nucleic acids Optimized by Scattering)R01GM105404 · NIGMS · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI TAINER, JOHN A. · 2012 to 2015
$2.1M
Howard Hughes Medical InstituteNCI NIH HHS P30 CA016058NIA NIH HHS U19 AG065156NIGMS NIH HHS K12 GM081266NIGMS NIH HHS P30 GM124169NIGMS NIH HHS P41 GM103533NIGMS NIH HHS P41 GM128577NIGMS NIH HHS R01 GM105404NIGMS NIH HHS T32 GM007810
6 · The paper itself

Abstract

Kinases play central roles in signaling cascades, relaying information from the outside to the inside of mammalian cells. De novo designed protein switches capable of interfacing with tyrosine kinase signaling pathways would open new avenues for controlling cellular behavior, but, so far, no such systems have been described. Here we describe the de novo design of two classes of protein switch that link phosphorylation by tyrosine and serine kinases to protein-protein association. In the first class, protein-protein association is required for phosphorylation by the kinase, while in the second class, kinase activity drives protein-protein association. We design systems that couple protein binding to kinase activity on the immunoreceptor tyrosine-based activation motif central to T-cell signaling, and kinase activity to reconstitution of green fluorescent protein fluorescence from fragments and the inhibition of the protease calpain. The designed switches are reversible and function in vitro and in cells with up to 40-fold activation of switching by phosphorylation.

Indexed as

Amino Acid MotifsBinding, CompetitiveCalcium-Binding ProteinsCalpainCatalysisCatalytic DomainCell LineCyclic AMP-Dependent Protein KinasesDrug DesignGenes, SyntheticGreen Fluorescent ProteinsHumansHydrogen BondingModels, MolecularPhosphorylationPhosphotyrosineCalcium-Binding ProteinsCalpaincalpastatinCyclic AMP-Dependent Protein KinasesGreen Fluorescent ProteinsPhosphotyrosineProtein Serine-Threonine KinasesProtein-Tyrosine KinasesRecombinant Proteinssrc-Family Kinases

Identifiers

PMID34518698
PMCPMC8601088
OpenAlexW3200308012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.